Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1957 1
1971 5
1972 9
1973 4
1974 1
1976 1
1977 3
1979 3
1980 1
1981 1
1983 2
1984 1
1986 2
1987 2
1988 2
1989 7
1990 5
1991 6
1992 8
1993 9
1994 17
1995 19
1996 18
1997 9
1998 18
1999 9
2000 20
2001 16
2002 18
2003 12
2004 10
2005 11
2006 10
2007 18
2008 18
2009 13
2010 21
2011 16
2012 18
2013 25
2014 23
2015 21
2016 13
2017 18
2018 23
2019 18
2020 15
2021 10
2022 4
2023 12
2024 11
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

531 results

Results by year

Filters applied: . Clear all
Page 1
DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling.
Tusseau M, Lovšin E, Samaille C, Pescarmona R, Mathieu AL, Maggio MC, Selmanović V, Debeljak M, Dachy A, Novljan G, Janin A, Januel L, Gibier JB, Chopin E, Rouvet I, Goncalves D, Fabien N, Rice GI, Lesca G, Labalme A, Romagnani P, Walzer T, Viel S, Perret M, Crow YJ, Avčin T, Cimaz R, Belot A. Tusseau M, et al. Among authors: janin a. J Clin Immunol. 2022 Aug;42(6):1310-1320. doi: 10.1007/s10875-022-01287-5. Epub 2022 Jun 7. J Clin Immunol. 2022. PMID: 35670985
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
Angeli E, Paris J, Le Tilly O, Desvignes C, Gapihan G, Boquet D, Pamoukdjian F, Hamdan D, Rigal M, Poirier F, Lutomski D, Azibani F, Mebazaa A, Herbet A, Mabondzo A, Falgarone G, Janin A, Paintaud G, Bousquet G. Angeli E, et al. Among authors: janin a. Exp Hematol Oncol. 2024 Apr 15;13(1):41. doi: 10.1186/s40164-024-00513-7. Exp Hematol Oncol. 2024. PMID: 38622749 Free PMC article.
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice.
Mattè A, Kosinski PA, Federti E, Dang L, Recchiuti A, Russo R, Siciliano A, Riccardi V, Janin A, Mucci M, Leboeuf C, Iolascon A, Brugnara C, De Franceschi L. Mattè A, et al. Among authors: janin a. Haematologica. 2023 Sep 1;108(9):2535-2541. doi: 10.3324/haematol.2022.282614. Haematologica. 2023. PMID: 36794508 Free PMC article. No abstract available.
[Multinucleate cells angiohistiocytoma].
Leclerc S, Clerici T, Rybojad M, Girszyn N, Morel P, Janin A, Vignon-Pennamen MD. Leclerc S, et al. Among authors: janin a. Ann Dermatol Venereol. 2005 Jun-Jul;132(6-7 Pt 1):546-9. doi: 10.1016/s0151-9638(05)79336-4. Ann Dermatol Venereol. 2005. PMID: 16142103 French.
531 results